Search research articles
Contact Us
Filters
Showing results (81-90 of 108) with videos related to
Page
of 11
Sort By:
The Journal of Antimicrobial Chemotherapy
|
August 11, 2021
Comparison of phenotypic antimicrobial susceptibility testing results and WGS-derived genotypic resistance profiles for a cohort of ESBL-producing Escherichia coli collected from Canadian hospitals: CANWARD 2007-18
Alyssa R Golden, James A Karlowsky, Andrew Walkty, et al.
Diagnostic Microbiology and Infectious Disease
|
June 3, 2008
Antimicrobial susceptibility of 3931 organisms isolated from intensive care units in Canada: Canadian National Intensive Care Unit Study, 2005/2006
George G Zhanel, Mel DeCorby, Kim A Nichol, et al.
The Journal of Antimicrobial Chemotherapy
|
August 28, 2025
Characterization of ertapenem-resistant Enterobacterales in Canadian hospitals: 17 years of the CANWARD study (2007-23)
Laura F Mataseje, Nicole Lerminiaux, Philippe Lagacé-Wiens, et al.
Expert Review of Anti-Infective Therapy
|
April 20, 2012
Comparison of the next-generation aminoglycoside plazomicin to gentamicin, tobramycin and amikacin
George G Zhanel, Christopher D Lawson, Sheryl Zelenitsky, et al.
Drugs
|
February 11, 2016
Review of Eravacycline, a Novel Fluorocycline Antibacterial Agent
George G Zhanel, Doris Cheung, Heather Adam, et al.
Jac-Antimicrobial Resistance
|
February 14, 2022
Activity of cefepime/taniborbactam and comparators against whole genome sequenced ertapenem-non-susceptible Enterobacterales clinical isolates: CANWARD 2007-19
Alyssa R Golden, Melanie R Baxter, James A Karlowsky, et al.
Expert Review of Anti-Infective Therapy
|
September 26, 2024
Ceftolozane/Tazobactam treatment for patients with hospital-acquired and ventilatory-associated bacterial pneumonia in Canada in 2022-2024: results from the CLEAR registry
George G Zhanel, Rita Dhami, Melanie Baxter, et al.
The Journal of Antimicrobial Chemotherapy
|
April 17, 2013
Antimicrobial susceptibility of 22746 pathogens from Canadian hospitals: results of the CANWARD 2007-11 study
George G Zhanel, Heather J Adam, Melanie R Baxter, et al.
Journal of Global Antimicrobial Resistance
|
June 22, 2024
Real-life experience with IV dalbavancin in Canada; results from the CLEAR (Canadian LEadership on Antimicrobial Real-life usage) registry
George Zhanel, Michael Silverman, Janhavi Malhotra, et al.
Journal of Global Antimicrobial Resistance
|
February 4, 2021
Real-life experience with ceftobiprole in Canada: Results from the CLEAR (CanadianLEadership onAntimicrobialReal-life usage) registry
George G Zhanel, Justin Kosar, Melanie Baxter, et al.
Page
of 11
Search research articles
Search
Showing results (81-90 of 108) with videos related to
Sort By:
Page
of 11
The Journal of Antimicrobial Chemotherapy
|
August 11, 2021
Comparison of phenotypic antimicrobial susceptibility testing results and WGS-derived genotypic resistance profiles for a cohort of ESBL-producing Escherichia coli collected from Canadian hospitals: CANWARD 2007-18
Alyssa R Golden, James A Karlowsky, Andrew Walkty, et al.
Diagnostic Microbiology and Infectious Disease
|
June 3, 2008
Antimicrobial susceptibility of 3931 organisms isolated from intensive care units in Canada: Canadian National Intensive Care Unit Study, 2005/2006
George G Zhanel, Mel DeCorby, Kim A Nichol, et al.
The Journal of Antimicrobial Chemotherapy
|
August 28, 2025
Characterization of ertapenem-resistant Enterobacterales in Canadian hospitals: 17 years of the CANWARD study (2007-23)
Laura F Mataseje, Nicole Lerminiaux, Philippe Lagacé-Wiens, et al.
Expert Review of Anti-Infective Therapy
|
April 20, 2012
Comparison of the next-generation aminoglycoside plazomicin to gentamicin, tobramycin and amikacin
George G Zhanel, Christopher D Lawson, Sheryl Zelenitsky, et al.
Drugs
|
February 11, 2016
Review of Eravacycline, a Novel Fluorocycline Antibacterial Agent
George G Zhanel, Doris Cheung, Heather Adam, et al.
Jac-Antimicrobial Resistance
|
February 14, 2022
Activity of cefepime/taniborbactam and comparators against whole genome sequenced ertapenem-non-susceptible Enterobacterales clinical isolates: CANWARD 2007-19
Alyssa R Golden, Melanie R Baxter, James A Karlowsky, et al.
Expert Review of Anti-Infective Therapy
|
September 26, 2024
Ceftolozane/Tazobactam treatment for patients with hospital-acquired and ventilatory-associated bacterial pneumonia in Canada in 2022-2024: results from the CLEAR registry
George G Zhanel, Rita Dhami, Melanie Baxter, et al.
The Journal of Antimicrobial Chemotherapy
|
April 17, 2013
Antimicrobial susceptibility of 22746 pathogens from Canadian hospitals: results of the CANWARD 2007-11 study
George G Zhanel, Heather J Adam, Melanie R Baxter, et al.
Journal of Global Antimicrobial Resistance
|
June 22, 2024
Real-life experience with IV dalbavancin in Canada; results from the CLEAR (Canadian LEadership on Antimicrobial Real-life usage) registry
George Zhanel, Michael Silverman, Janhavi Malhotra, et al.
Journal of Global Antimicrobial Resistance
|
February 4, 2021
Real-life experience with ceftobiprole in Canada: Results from the CLEAR (CanadianLEadership onAntimicrobialReal-life usage) registry
George G Zhanel, Justin Kosar, Melanie Baxter, et al.
Page
of 11